English | Español
Patient Daily | Nov 26, 2025

UTHealth Houston receives NIH grant to study long-term results of spina bifida treatment
Patient Daily | Nov 26, 2025

EPA delays methane emission rules despite concerns raised by lung association
Patient Daily | Nov 25, 2025

JK Strategies Founder Kalavritinos on 340B abuse: 'Money was not going to the people who needed it'
Patient Daily | Nov 25, 2025

Government extends Soft Drinks Levy to include sugary milk-based beverages
Patient Daily | Nov 25, 2025

Tobacco Free Action Communities marks 25 years fighting tobacco use in New York
Patient Daily | Nov 25, 2025

Bliksem Health founder Rojas on 340B reform: '340B has been weaponised by the largest entities and must be cut off'
Patient Daily | Nov 21, 2025

Texas voters approve $3 billion funding plan for new Dementia Prevention institute
Patient Daily | Nov 21, 2025

Oral Health Foundation highlights lasting impact of mouth cancer on diet

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor